Gilead issues a voluntary recall of one lot of VistideĀ® (CIDOFOVIR INJECTION)
date:Feb 16, 2013
tly to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax:

Online: www.fda.gov/medwatch/report.htm
Regular Mail: use postage-paid, pre-addressed Form FDA 3500 available at:
www.fda.gov/MedWatch/getforms.htm. Mail to address on the pre-addressed form.
Fax: 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
6/6 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/05 16:57